Precision BioSciences Receives U.S. Patent Allowances Covering the PBGENE-HBV Program

Go back to Precision BioSciences Receives U.S. Patent Allowances Covering the PBGENE-HBV Program
(NASDAQ: DTIL) Delayed: 7.51 +0.05 (0.67%)
Previous Close $7.46    52 Week High
Open $7.48    52 Week Low
Day High $7.63    P/E N/A 
Day Low $7.36    EPS
Volume 345,174